Close Menu

NEW YORK (GenomeWeb) – New England Biolabs and startup company CasZyme announced today that they have formed a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases.

Under the terms of the agreement, the two companies will work to characterize new Cas nucleases using their expertise in enzymology, and NEB will then manufacture and commercially distribute the nucleases globally.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.